US conditionally clears Integra/Codman Neuro after UK waves through
Integra LifeSciences has agreed to divest a range of healthcare product lines to nab US clearance for its acquisition of Johnson & Johnson’s neurosurgery medical products business – a deal already unconditionally cleared in the UK on the de minimis exception.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.